20 December 2019
Publication of Prospectus
The following prospectus has been approved by the Financial Conduct Authority and is available for viewing:
Prospectus dated 20 December 2019 (the "Prospectus"), relating to M&G plc's £10,000,000,000 Medium Term Note Programme.
To view the full document, please paste the following URL into the address bar of your browser:
A copy of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM.
+44 20 3977 1426
+44 20 3977 0165
+44 20 3977 7888 Spencer.Horgan@Prudential.co.uk
Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
The Prospectus does not constitute an offer of securities for sale in the United States. The securities described herein (the "Notes") have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered in the United States of America or to, or for the account of or benefit of, U.S. persons, as such terms are defined in Regulation S under the Securities Act.
Your right to access this service is conditional upon complying with the above requirement.
M&G plc LEI: 254900TWUJUQ44TQJY84.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com or visit www.rns.com.